Synektik S.A. (SNT)
Warsaw Stock Exchange · Poland · prices in PLN · close of 22 Oct 2026
Key indicators
| Last close | PLN 336.00 |
|---|---|
| 52-week range | 245.20 – 398.40 |
| Return, 1 month / 3 months | −4.9% / −9.7% |
| Return, 1 year / 3 years | +36.7% / +519.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 12.20M PLN |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Synektik S.A. is a Polish medical technology company based in Warsaw. It supplies hospitals and healthcare providers with medical equipment and technology, including robotic surgical systems, and it develops its own software and imaging systems used in nuclear medicine and radiotherapy. Its work spans distribution of third-party medical devices alongside in-house technology products, serving clinical customers in Poland and neighbouring markets.
On this site Synektik S.A. appears as a stock on the Warsaw Stock Exchange (Poland), code SNT, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Synektik S.A. (SNT) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 336.00 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 62 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.7% and over the last three months it fell 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.4% | ||
| From 52-week high | -14.7% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.7% | ||
| 6-month return | 14.9% | ||
| 12-month return, skipping the last month | 43.7% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 12.20M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | −4.9% |
| 3 months | −9.7% |
| 6 months | +14.9% |
| 1 year | +36.7% |
| 3 years | +519.2% |
| 5 years | +1,217.0% |
Signals
| 50-day / 200-day average | 343.39 / 315.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Jan 2026 | PLN 10.7500 |
| 27 Jan 2025 | PLN 5.6305 |
| 1 Mar 2024 | PLN 2.0679 |
| 28 Feb 2023 | PLN 0.4095 |
| 9 Feb 2022 | PLN 0.3071 |
| 17 Feb 2021 | PLN 0.3071 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.